Literature DB >> 21165378

Pay now or pay (more) later: tracking the costs of hepatitis C infection.

Robert P Myers, Samuel S Lee.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 21165378      PMCID： PMC3004443          DOI： 10.1155/2010/526295

Source DB:  PubMed          Journal:  Can J Gastroenterol        ISSN： 0835-7900            Impact factor:   3.522


× No keyword cloud information.
  8 in total

Review 1.  The global burden of hepatitis C.

Authors:  Daniel Lavanchy
Journal:  Liver Int       Date:  2009-01       Impact factor: 5.828

2.  Prediction of hepatitis C burden in Canada.

Authors:  S Zou; M Tepper; S El Saadany
Journal:  Can J Gastroenterol       Date:  2000 Jul-Aug       Impact factor: 3.522

3.  Historical features are poor predictors of liver fibrosis in Canadian patients with chronic hepatitis C.

Authors:  R P Myers; R J Hilsden; S S Lee
Journal:  J Viral Hepat       Date:  2001-07       Impact factor: 3.728

4.  Health care costs associated with hepatitis C: a longitudinal cohort study.

Authors:  Mel Krajden; Margot Kuo; Brandon Zagorski; Maria Alvarez; Amanda Yu; Murray Krahn
Journal:  Can J Gastroenterol       Date:  2010-12       Impact factor: 3.522

5.  Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression.

Authors:  Gary L Davis; Miriam J Alter; Hashem El-Serag; Thierry Poynard; Linda W Jennings
Journal:  Gastroenterology       Date:  2009-10-25       Impact factor: 22.682

6.  The changing direct costs of medical care for patients with HIV/AIDS, 1995-2001.

Authors:  Hartmut B Krentz; M Christopher Auld; M John Gill
Journal:  CMAJ       Date:  2003-07-22       Impact factor: 8.262

7.  The burden of hepatitis C virus infection is growing: a Canadian population-based study of hospitalizations from 1994 to 2004.

Authors:  Robert P Myers; MingFu Liu; Abdel Aziz Shaheen
Journal:  Can J Gastroenterol       Date:  2008-04       Impact factor: 3.522

8.  Improving access to care by allowing self-referral to a hepatitis C clinic.

Authors:  K E Doucette; V Robson; S Shafran; D Kunimoto
Journal:  Can J Gastroenterol       Date:  2009-06       Impact factor: 3.522
  8 in total
  1 in total

1.  Outcomes of chronic hepatitis C therapy in patients treated in community versus academic centres in Canada: final results of APPROACH (a prospective study of peginterferon alfa-2a and ribavirin at academic and community centres in Canada).

Authors:  Robert P Myers; Curtis Cooper; Morris Sherman; Richard Lalonde; Helga Witt-Sullivan; Magdy Elkashab; Paul Harris; Robert Balshaw; Chistopher Usaty; Paul J Marrotta
Journal:  Can J Gastroenterol       Date:  2011-09       Impact factor: 3.522
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.